Get the Stockscreener App
1.57
0.32%
0.005
Aprea Therapeutics Inc stock is traded at $1.57, with a volume of 17,303.
It is up +0.32% in the last 24 hours and down -5.42% over the past month.
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
See More
Previous Close:
$1.565
Open:
$1.57
24h Volume:
17,303
Relative Volume:
0.35
Market Cap:
$9.15M
Revenue:
-
Net Income/Loss:
$-14.29M
P/E Ratio:
-0.3935
EPS:
-3.99
Net Cash Flow:
$-12.27M
1W Performance:
-0.63%
1M Performance:
-5.42%
6M Performance:
-38.03%
1Y Performance:
-54.21%
1-Day Range:
$1.51
$1.57
1-Week Range:
$1.51
$1.65
52-Week Range:
$1.412
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Name
Aprea Therapeutics Inc
Sector
Industry
Phone
215-948-4119
Address
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Compare APRE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.57 | 9.12M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-28-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-16-20 | Initiated | Berenberg | Buy |
| Sep-29-20 | Resumed | JP Morgan | Neutral |
| Jun-22-20 | Initiated | H.C. Wainwright | Neutral |
| Apr-21-20 | Initiated | Robert W. Baird | Outperform |
| Oct-28-19 | Initiated | JP Morgan | Neutral |
| Oct-28-19 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-28-19 | Initiated | RBC Capital Mkts | Outperform |
View All
Aprea Therapeutics Inc Stock (APRE) Latest News
Can technical indicators confirm Aprea Therapeutics Inc.’s reversalTrade Analysis Report & Risk Managed Trade Strategies - Newser
Identifying reversal signals in Aprea Therapeutics Inc.Market Activity Report & Growth Oriented Trade Recommendations - Newser
Price action breakdown for Aprea Therapeutics Inc.Quarterly Growth Report & Weekly High Return Opportunities - Newser
What institutional flow reveals about Aprea Therapeutics Inc.CEO Change & Daily Profit Maximizing Tips - Newser
Should you hold or exit Aprea Therapeutics Inc. nowMarket Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Aprea Therapeutics Inc. recovery potential after sell offJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
Can a trend reversal in Aprea Therapeutics Inc. lead to recovery2025 Major Catalysts & Accurate Technical Buy Alerts - Newser
Is Aprea Therapeutics Inc. stock influenced by commodity prices2025 Momentum Check & Capital Protection Trade Alerts - خودرو بانک
What drives Aprea Therapeutics Inc.’s stock price2025 Fundamental Recap & Stock Portfolio Risk Management - خودرو بانک
Aprea Therapeutics Inc.’s volatility index tracking explainedPortfolio Performance Summary & Low Risk Entry Point Guides - Newser
What is Aprea Therapeutics Inc.’s market positionQuarterly Performance Summary & Community Consensus Stock Picks - خودرو بانک
Using RSI to spot recovery in Aprea Therapeutics Inc.2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Is Aprea Therapeutics Inc. forming a bullish divergenceQuarterly Profit Report & Weekly Setup with High ROI Potential - خودرو بانک
Chart based exit strategy for Aprea Therapeutics Inc.July 2025 Momentum & Short-Term Swing Trade Alerts - Newser
Will Aprea Therapeutics Inc. benefit from geopolitical trendsQuarterly Profit Report & Real-Time Volume Spike Alerts - خودرو بانک
Trend analysis for Aprea Therapeutics Inc. this weekMarket Risk Analysis & Weekly High Return Opportunities - Newser
Visual analytics tools that track Aprea Therapeutics Inc. performanceJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - Newser
What’s next for Aprea Therapeutics Inc. stock priceEntry Point & Free AI Powered Buy and Sell Recommendations - Newser
What is Aprea Therapeutics Inc.’s valuation compared to sectorMarket Sentiment Summary & Stepwise Trade Signal Implementation - خودرو بانک
Is Aprea Therapeutics Inc. stock a good pick for beginnersTrade Entry Report & Fast Entry Momentum Alerts - خودرو بانک
Analyzing Aprea Therapeutics Inc. with multi timeframe chartsJuly 2025 Selloffs & Verified High Yield Trade Plans - Newser
Aprea Therapeutics Inc. stock daily chart insightsMarket Movers & AI Enhanced Execution Alerts - Newser
Using R and stats models for Aprea Therapeutics Inc. forecasting2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Comparing Aprea Therapeutics Inc. in custom built stock radars2025 Momentum Check & High Accuracy Swing Trade Signals - Newser
Real time breakdown of Aprea Therapeutics Inc. stock performanceMarket Movement Recap & Free Low Drawdown Momentum Trade Ideas - Newser
How moving averages guide Aprea Therapeutics Inc. tradingWeekly Trade Recap & Daily Profit Maximizing Trade Tips - Newser
Market reaction to Aprea Therapeutics Inc.’s recent newsQuarterly Profit Review & Low Risk Entry Point Guides - Newser
Volatility clustering patterns for Aprea Therapeutics Inc.2025 Market Outlook & Long Hold Capital Preservation Tips - Newser
Multi factor analysis applied to Aprea Therapeutics Inc.2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Backtesting results for Aprea Therapeutics Inc. trading strategiesMarket Trend Summary & Reliable Intraday Trade Plans - Newser
Pattern recognition hints at Aprea Therapeutics Inc. upsideTrade Analysis Summary & Safe Capital Growth Trade Ideas - Newser
Sentiment Tools Show Shift in Trader Mood on Aprea Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Intraday Charts Show Spike in Aprea Therapeutics Inc. Activity getLinesFromResByArray error: size == 0 - kangso.co.kr
Chart overlay techniques for tracking Aprea Therapeutics Inc.Quarterly Profit Summary & Precise Buy Zone Identification - Newser
Short interest data insights for Aprea Therapeutics Inc.Market Volume Report & Weekly Top Stock Performers List - Newser
Can you recover from losses in Aprea Therapeutics Inc.July 2025 Market Mood & Safe Entry Trade Reports - Newser
What candlestick patterns are forming on Aprea Therapeutics Inc.2025 Earnings Surprises & Safe Entry Momentum Tips - Newser
Aprea Therapeutics Inc Stock (APRE) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):